Sarm1 knockout is sufficient to protect nerve axon structure and function in animal models of traumatic axonal injury (27); chemotherapy-induced, inflammatory, and CMT2A models of peripheral neuropathy (28–30); as well as mouse models of both T1D- and T2D-associated DPN (31, 32). Here, SARM1 is linked to type 1 diabetes mellitus.